Thomas. Enzler, et.al., Deficiencies of GM-CSF and interferon gamma link inflammation and cancer., The Journal of experimental medicine, 2003, 197

http://rdf.ncbi.nlm.nih.gov/pubmed/12732663

Thomas. Enzler, et.al., Deficiencies of GM-CSF and interferon gamma link inflammation and cancer., The Journal of experimental medicine, 2003, 197

pubmed

表現型アノテーション

http://purl.org/net/cito/citesAsAuthority

• abnormal surfactant secretion_Csf2<tm1Dran>/Csf2<tm1Dran>,Il3<tm1Glli>/Il3<tm1Glli>
  http://metadb.riken.jp/0004780B6129S2Csf2tm1DranIl3tm1GlliCsf2tm1DranCsf2tm1DranIl3tm1GlliIl3tm1GlliIl3tm1GlliCsf2tm1Dran
• increased ovarian carcinoma incidence_Csf2<tm1Dran>/Csf2<tm1Dran>,Ifng<tm1Ts>/Ifng<tm1Ts>,Il3<tm1Glli>/Il3<tm1Glli>
  http://metadb.riken.jp/0003579I129S2SvPas129S7SvEvBrdC57BL6Csf2tm1DranCsf2tm1DranIfngtm1TsIfngtm1TsIl3tm1GlliIl3tm1GlliIfngtm1TsIl3tm1GlliCsf2tm1Dran
• increased immunoglobulin level_Csf2<tm1Dran>/Csf2<tm1Dran>,Ifng<tm1Ts>/Ifng<tm1Ts>,Il3<tm1Glli>/Il3<tm1Glli>
  http://metadb.riken.jp/0002461I129S2SvPas129S7SvEvBrdC57BL6Csf2tm1DranCsf2tm1DranIfngtm1TsIfngtm1TsIl3tm1GlliIl3tm1GlliIfngtm1TsIl3tm1GlliCsf2tm1Dran
• increased inflammatory response_Csf2<tm1Dran>/Csf2<tm1Dran>,Ifng<tm1Ts>/Ifng<tm1Ts>,Il3<tm1Glli>/Il3<tm1Glli>
  http://metadb.riken.jp/0001846I129S2SvPas129S7SvEvBrdC57BL6Csf2tm1DranCsf2tm1DranIfngtm1TsIfngtm1TsIl3tm1GlliIl3tm1GlliIfngtm1TsIl3tm1GlliCsf2tm1Dran
• increased B cell derived lymphoma incidence_Csf2<tm1Dran>/Csf2<tm1Dran>,Ifng<tm1Ts>/Ifng<tm1Ts>,Il3<tm1Glli>/Il3<tm1Glli>
  http://metadb.riken.jp/0002023I129S2SvPas129S7SvEvBrdC57BL6Csf2tm1DranCsf2tm1DranIfngtm1TsIfngtm1TsIl3tm1GlliIl3tm1GlliIfngtm1TsIl3tm1GlliCsf2tm1Dran
• glomerulonephritis_Csf2<tm1Dran>/Csf2<tm1Dran>,Il3<tm1Glli>/Il3<tm1Glli>
  http://metadb.riken.jp/0002743B6129S2Csf2tm1DranIl3tm1GlliCsf2tm1DranCsf2tm1DranIl3tm1GlliIl3tm1GlliIl3tm1GlliCsf2tm1Dran
• increased carcinoma incidence_Csf2<tm1Dran>/Csf2<tm1Dran>,Ifng<tm1Ts>/Ifng<tm1Ts>,Il3<tm1Glli>/Il3<tm1Glli>
  http://metadb.riken.jp/0002038I129S2SvPas129S7SvEvBrdC57BL6Csf2tm1DranCsf2tm1DranIfngtm1TsIfngtm1TsIl3tm1GlliIl3tm1GlliIfngtm1TsIl3tm1GlliCsf2tm1Dran
• increased IgG1 level_Csf2<tm1Dran>/Csf2<tm1Dran>,Ifng<tm1Ts>/Ifng<tm1Ts>,Il3<tm1Glli>/Il3<tm1Glli>
  http://metadb.riken.jp/0008499I129S2SvPas129S7SvEvBrdC57BL6Csf2tm1DranCsf2tm1DranIfngtm1TsIfngtm1TsIl3tm1GlliIl3tm1GlliIfngtm1TsIl3tm1GlliCsf2tm1Dran
• postnatal lethality, incomplete penetrance_Csf2<tm1Dran>/Csf2<tm1Dran>,Ifng<tm1Ts>/Ifng<tm1Ts>,Il3<tm1Glli>/Il3<tm1Glli>
  http://metadb.riken.jp/0011086I129S2SvPas129S7SvEvBrdC57BL6Csf2tm1DranCsf2tm1DranIfngtm1TsIfngtm1TsIl3tm1GlliIl3tm1GlliIfngtm1TsIl3tm1GlliCsf2tm1Dran
• increased eosinophil cell number_Csf2<tm1Dran>/Csf2<tm1Dran>,Ifng<tm1Ts>/Ifng<tm1Ts>,Il3<tm1Glli>/Il3<tm1Glli>
  http://metadb.riken.jp/0005011I129S2SvPas129S7SvEvBrdC57BL6Csf2tm1DranCsf2tm1DranIfngtm1TsIfngtm1TsIl3tm1GlliIl3tm1GlliIfngtm1TsIl3tm1GlliCsf2tm1Dran
• premature death_Csf2<tm1Dran>/Csf2<tm1Dran>,Ifng<tm1Ts>/Ifng<tm1Ts>,Il3<tm1Glli>/Il3<tm1Glli>
  http://metadb.riken.jp/0002083I129S2SvPas129S7SvEvBrdC57BL6Csf2tm1DranCsf2tm1DranIfngtm1TsIfngtm1TsIl3tm1GlliIl3tm1GlliIfngtm1TsIl3tm1GlliCsf2tm1Dran
• increased IgE level_Csf2<tm1Dran>/Csf2<tm1Dran>,Ifng<tm1Ts>/Ifng<tm1Ts>,Il3<tm1Glli>/Il3<tm1Glli>
  http://metadb.riken.jp/0002497I129S2SvPas129S7SvEvBrdC57BL6Csf2tm1DranCsf2tm1DranIfngtm1TsIfngtm1TsIl3tm1GlliIl3tm1GlliIfngtm1TsIl3tm1GlliCsf2tm1Dran
• increased anti-double stranded DNA antibody level_Csf2<tm1Dran>/Csf2<tm1Dran>,Il3<tm1Glli>/Il3<tm1Glli>
  http://metadb.riken.jp/0004762B6129S2Csf2tm1DranIl3tm1GlliCsf2tm1DranCsf2tm1DranIl3tm1GlliIl3tm1GlliIl3tm1GlliCsf2tm1Dran
• abnormal leukocyte physiology_Csf2<tm1Dran>/Csf2<tm1Dran>,Il3<tm1Glli>/Il3<tm1Glli>
  http://metadb.riken.jp/0002442B6129S2Csf2tm1DranIl3tm1GlliCsf2tm1DranCsf2tm1DranIl3tm1GlliIl3tm1GlliIl3tm1GlliCsf2tm1Dran